Skip to main content
. 2019 Jul 2;16(7):e1002847. doi: 10.1371/journal.pmed.1002847

Fig 2. Association of p65 nuclear frequency with prostate cancer patient outcome.

Fig 2

Kaplan–Meier curves for (A, B) BCR-free survival, (C, D) bone-metastasis-free survival, and (E) prostate-cancer-specific survival, stratified by negative/low (0%–3%) and high (>3%) p65 nuclear expression in prostate cancer cells. p-Values are calculated using the log-rank test. p < 0.05 is considered significant. BCR, biochemical recurrence.